Suchergebnisse - Adrian Bot

Treffer weiter einschränken
  1. 1
    Protective Role of Gamma Interferon during the Recall Response to Influenza Virus

    Protective Role of Gamma Interferon during the Recall Response to Influenza Virus von Adrian Bot, Simona Bot, Constantin A. Bona

    Veröffentlicht 1998
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL

    Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL von Zachary Roberts, Marc Better, Adrian Bot, Margo R. Roberts, Antoni Ribas

    Veröffentlicht 2017
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract.

    Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract. von Adrian Bot, Thomas E. Tarara, Daniel J. Smıth, Simona Bot, Catherine M. Woods, Jeffry G. Weers

    Veröffentlicht 2000
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Liquid biopsy approach to monitor the efficacy and response to CAR-T cell therapy

    Liquid biopsy approach to monitor the efficacy and response to CAR-T cell therapy von Stephanie N. Shishido, Olivia Hart, Sujin Jeong, Aidan Moriarty, Darren Heeke, John M. Rossi, Adrian Bot, Peter Kühn

    Veröffentlicht 2024
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Plasmid Vaccination with Insulin B Chain Prevents Autoimmune Diabetes in Nonobese Diabetic Mice

    Plasmid Vaccination with Insulin B Chain Prevents Autoimmune Diabetes in Nonobese Diabetic Mice von Adrian Bot, Daniel J. Smıth, Simona Bot, Anna C. Hughes, Tom Wolfe, Xin Lin, C. G. Woods, Matthias von Herrath

    Veröffentlicht 2001
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Autoreactive CD4+ T Cells Protect from Autoimmune Diabetes via Bystander Suppression Using the IL-4/Stat6 Pathway

    Autoreactive CD4+ T Cells Protect from Autoimmune Diabetes via Bystander Suppression Using the IL-4/Stat6 Pathway von Dirk Homann, Andreas Holz, Adrian Bot, Bryan Coon, Tom Wolfe, Jacob Petersen, Thomas Dyrberg, Michael J. Grusby, Matthias G. von Herrath

    Veröffentlicht 1999
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors

    A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors von Jeffrey S. Weber, Nicholas J. Vogelzang, Marc S. Ernstoff, Oscar B. Goodman, Lee D. Cranmer, John L. Marshall, Sabrina Miles, Dar Rosario, David C. Diamond, Zhiyong Qiu, Mihail Obrocea, Adrian Bot

    Veröffentlicht 2011
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy

    Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy von James N. Kochenderfer, Robert Somerville, Tangying Lu, James C. Yang, Richard M. Sherry, Steven A. Feldman, Lori McIntyre, Adrian Bot, John M. Rossi, Norris Lam, Steven A. Rosenberg

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Intra–Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical Trial

    Intra–Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical Trial von Antoni Ribas, Jeffrey S. Weber, Bartosz Chmielowski, Begonya Comin-Anduix, David Lu, Michael Douek, Nagesh Ragavendra, Steve Raman, Elizabeth Seja, Darlene Rosario, Sabrina Miles, David C. Diamond, Zhiyong Qiu, Mihail Obrocea, Adrian Bot

    Veröffentlicht 2011
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Antigen kinetics determines immune reactivity

    Antigen kinetics determines immune reactivity von Pål Johansen, Tazio Storni, Lorna Rettig, Zhiyong Qiu, Ani Der-Sarkissian, Kevin M. Smith, Vania Manolova, Karl S. Lang, Gabriela Senti, Beat Müllhaupt, Tilman Gerlach, Roberto F. Speck, Adrian Bot, Thomas M. Kündig

    Veröffentlicht 2008
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy

    Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy von Pei-Hsuan Chen, Mikel Lipschitz, Jason L. Weirather, Caron A. Jacobson, Philippe Armand, Kyle Wright, F. Stephen Hodi, Zachary Roberts, Stuart A. Sievers, John M. Rossi, Adrian Bot, William Y. Go, Scott J. Rodig

    Veröffentlicht 2020
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL

    Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL von John M. Rossi, Patrick Paczkowski, Yueh-wei Shen, Kevin Morse, Brianna Flynn, Alaina Kaiser, Colin Ng, Kyle Gallatin, Tom Cain, Rong Fan, Sean Mackay, James R. Heath, Steven A. Rosenberg, James N. Kochenderfer, Jing Zhou, Adrian Bot

    Veröffentlicht 2018
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

    Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma von Frederick L. Locke, Sattva S. Neelapu, Nancy L. Bartlett, Tanya Siddiqi, Julio C. Chávez, Chitra Hosing, Armin Ghobadi, Lihua E. Budde, Adrian Bot, John M. Rossi, Yizhou Jiang, Allen Xue, Meg Elias, Jeff Aycock, Jeff Wiezorek, William Y. Go

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy

    A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy von Ranjan Upadhyay, Jonathan Boiarsky, Gvantsa Pantsulaia, Judit Svensson‐Arvelund, Matthew J. Lin, Aleksandra Wroblewska, Sherry Bhalla, Nathalie Scholler, Adrian Bot, John M. Rossi, Norah Sadek, Samir Parekh, Alessandro Laganá, Alessia Baccarini, Miriam Mérad, Brian D. Brown, Joshua Brody

    Veröffentlicht 2021
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma

    Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma von Frederick L. Locke, John M. Rossi, Sattva S. Neelapu, Caron A. Jacobson, David B. Miklos, Armin Ghobadi, Olalekan O. Oluwole, Patrick M. Reagan, Lazaros J. Lekakis, Yi Lin, Marika Sherman, Marc Better, William Y. Go, Jeffrey S. Wiezorek, Allen Xue, Adrian Bot

    Veröffentlicht 2020
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation

    IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation von Caitlin M. Tilsed, Barzan A. Sadiq, Tyler E. Papp, Phurin Areesawangkit, Kenji Kimura, Estela Noguera-Ortega, John Scholler, Nicholas Cerda, Haig Aghajanian, Adrian Bot, Barbara L. Mui, Ying K. Tam, Drew Weissman, Carl H. June, Steven Μ. Albelda, Hamideh Parhiz

    Veröffentlicht 2024
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses

    Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses von Gabrielle Romain, Paolo Strati, Ali Rezvan, Mohsen Fathi, Irfan Bandey, Jay R T. Adolacion, Darren Heeke, Ivan Liadi, Mario L. Marques‐Piubelli, Luisa M. Solis, Ankit Mahendra, Francisco Vega, Laurence J.N. Cooper, Harjeet Singh, Mike Mattie, Adrian Bot, Sattva S. Neelapu, Navin Varadarajan

    Veröffentlicht 2022
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)

    Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7) von Simone Filosto, Saran Vardhanabhuti, Miguel Canales, Xavier Poiré, Lazaros J. Lekakis, Sven de Vos, Craig A. Portell, Zixing Wang, Christina To, Marco Schupp, Soumya Poddar, Tan Trinh, Carmen M. Warren, Ethan G. Aguilar, Justin A. Budka, Paul Cheng, Justin Chou, Adrian Bot, Rhine R. Shen, Jason R. Westin

    Veröffentlicht 2023
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

    Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma von Jennifer N. Brudno, Norris Lam, Danielle Vanasse, Yueh-wei Shen, Jeremy J. Rose, John M. Rossi, Allen Xue, Adrian Bot, Nathalie Scholler, Lekha Mikkilineni, Mark Roschewski, Robert M. Dean, Raúl E. Cachau, Philippe Youkharibache, Rashmika Patel, Brenna Hansen, David F. Stroncek, Steven A. Rosenberg, Ronald E. Gress, James N. Kochenderfer

    Veröffentlicht 2020
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma

    Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma von Max S. Topp, Tom van Meerten, Roch Houot, Monique C. Minnema, Krimo Bouabdallah, Pieternella J. Lugtenburg, Catherine Thiéblemont, Martin Wermke, Kevin Song, Irit Avivi, John Kuruvilla, Ulrich Dührsen, Yan Zheng, Saran Vardhanabhuti, Jinghui Dong, Adrian Bot, John M. Rossi, Vicki Plaks, Marika Sherman, Jenny J. Kim, A. Kerber, Marie José Kersten

    Veröffentlicht 2021
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: